siRNA screen of ES cell-derived motor neurons identifies novel regulators of tetanus toxin and neurotrophin receptor trafficking by Terenzio, M et al.
ORIGINAL RESEARCH ARTICLE
published: 20 May 2014
doi: 10.3389/fncel.2014.00140
siRNA screen of ES cell-derived motor neurons identifies
novel regulators of tetanus toxin and neurotrophin
receptor trafficking
Marco Terenzio1†, Matthew Golding1† and Giampietro Schiavo1,2*
1 Molecular NeuroPathobiology Laboratory, Cancer Research UK London Research Institute, London, UK
2 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, University College London, London, UK
Edited by:
Lawrence Rajendran, University
Zurich, Switzerland
Reviewed by:
Robert Weissert, University of
Regensburg, Germany
Philipp Koch, University of Bonn,
Germany
*Correspondence:
Giampietro Schiavo, Sobell
Department of Motor Neuroscience
and Movement Disorders, UCL
Institute of Neurology, University
College London, Queen Square,
London, WC1N 3BG, UK
e-mail: giampietro.schiavo@ucl.ac.uk
†Present address:
Marco Terenzio, Biological
Chemistry, Weizmann Institute of
Science, Rehovot, Israel;
Matthew Golding, Centre for
Microvascular Research, William
Harvey Research Institute, Barts and
The London School of Medicine and
Dentistry, Queen Mary, University
of London, London, UK
Neurons rely on the long-range transport of several signaling molecules such as
neurotrophins and their receptors, which are required for neuronal development, function
and survival. However, the nature of the machinery controlling the trafficking of signaling
endosomes containing activated neurotrophin receptors has not yet been completely
elucidated. We aimed to identify new players involved in the dynamics of neurotrophin
signaling endosomes using a medium-throughput unbiased siRNA screening approach to
quantify the intracellular accumulation of two fluorescently tagged reporters: the binding
fragment of tetanus neurotoxin (HCT), and an antibody directed against the neurotrophin
receptor p75NTR. This screen performed in motor neurons differentiated from mouse
embryonic stem (ES) cells identified a number of candidate genes encoding molecular
motors and motor adaptor proteins involved in regulating the intracellular trafficking of
these probes. Bicaudal D homolog 1 (BICD1), a molecular motor adaptor with pleiotropic
roles in intracellular trafficking, was selected for further analyses, which revealed that
BICD1 regulates the intracellular trafficking of HCT and neurotrophin receptors and likely
plays an important role in nervous system development and function.
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INTRODUCTION
The development, maintenance, and function of the vertebrate
nervous system rely on a complex network of signaling pathways
tightly regulated in space and time by different growth factors.
Amongst these, neurotrophins represent a very important class
of molecules, which activate two different types of receptors, the
Trk family of receptor tyrosine kinases and p75NTR, a member
of the TNF receptor superfamily. Upon neurotrophin binding at
the plasma membrane, Trk receptors are endocytosed and can
then either signal locally, or be retrogradely transported along
the axon to the neuronal cell body, where they initiate signaling
cascades leading to the long-term modulation of gene expression
(Heerssen and Segal, 2002).
Different types of neurons express distinct repertoires of Trk
receptors, which determine their responsiveness and reliance on
specific neurotrophins. In particular, motor neurons located in
the ventral horn of the spinal cord express TrkB, TrkC, and
p75NTR, and functionally connect skeletal muscles with the motor
cortex via the corticospinal tract. The survival of motor neu-
rons is ensured in vivo by neurotrophins secreted by their target
muscles. Once bound to the motor neuron surface, neurotrophin
receptor complexes are transported in axonal signaling endo-
somes, which ensure the long-range intracellular transport and
somatic endocytic sorting of these receptors (Bronfman et al.,
2007; Schmieg et al., 2013).
Interestingly, this route constitutes a major gateway for the
entry and dissemination of pathogens in the nervous system.
Specifically, motor neuron signaling endosomes mediate the
axonal transport of neurotropic viruses, such as poliovirus and
canine adenovirus 2 (Ohka et al., 2009; Salinas et al., 2009),
and clostridial neurotoxins, such as tetanus toxin (TeNT) and
botulinum neurotoxin (BoNT) (Restani et al., 2012; Bercsenyi
et al., 2013).
TeNT is taken up at the neuromuscular junction (NMJ)
and transported to the spinal cord, where it enters inhibitory
interneurons and blocks neurotransmitter release (Salinas et al.,
2010). The binding fragment of TeNT (HCT) has been shown
to share the same route of internalization and axonal retrograde
transport with neurotrophins and their receptors (Deinhardt
et al., 2006), and it has the advantages of being non-toxic and
readily expressed in a recombinant form with small peptide
tags suitable for chemical and fluorescent labeling (Bohnert and
Schiavo, 2005; Deinhardt et al., 2006). As such, HCT repre-
sents a reliable probe for the analysis of the axonal retrograde
transport of signaling endosomes in motor neurons in vitro
and in vivo.
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RNAi screens have been widely used to generate com-
plex datasets from image-based analysis of cell lines in high-
throughput formats (Krausz, 2007; Demir and Boutros, 2012).
However, highly proliferative cell lines do not constitute the most
physiologically relevant model system to study postmitotic cells
such as neurons. On the other hand, the use of primary motor
neurons for high-content image-based RNAi screens presents
daunting challenges because of the technical difficulties associ-
ated with generating enough cells, transfecting them efficiently
and imaging their complex morphology in a quantitative and
unbiased manner.
In spite of these obstacles, we developed a reliable protocol to
transfect motor neurons with a library of short interference RNAs
(siRNA) targeting a panel of molecular motors and their adap-
tors. This screen identified a small cohort of genes, which affected
the intracellular accumulation of HCT and p75NTR when silenced.
Knockdown of one gene in particular, bicaudal D homolog 1
(Bicd1) yielded an increased internalization phenotype for HCT
and was selected for further analyses, which demonstrated that
BICD1 depletion also increased the intracellular accumulation of
ligand-bound p75NTR and TrkB (Terenzio et al., 2014).
BICD1 is known to be involved in intracellular trafficking,
dynein-mediated transport (Hoogenraad et al., 2001; Matanis
et al., 2002; Bianco et al., 2010; Aguirre-Chen et al., 2011), and
has important roles in the development and function of the
Drosophila and C. elegans nervous systems (Li et al., 2010). We
now show that BICD1 is a key regulator of HCT and neurotrophin
receptor dynamics and performs this role by controlling the endo-
cytic sorting of HCT and neurotrophin receptors to regulate their
recycling to the plasma membrane. Our data identify a novel
function for BICD1 as a modulator of axonal signaling endosome
dynamics, which may also be relevant for different growth factor
receptors and virulence factors in other cellular systems.
MATERIALS AND METHODS
ETHICS STATEMENT
All experiments were carried out following the guidelines of the
Cancer Research UK genetic manipulation procedures.
REAGENTS AND ANTIBODIES
All chemicals were supplied by Sigma, unless stated other-
wise. Tissue culture media and supplements were from Life
Technologies.
The βIII tubulin (TUJ1) antibody was from Covance and the
Vamp2 antibody (clone 69.1) was from Synaptic Systems. The
characterization of the polyclonal antibody against the extracellu-
lar domain of p75NTR (αp75NTR; 5411) was previously described
(Deinhardt et al., 2007). The Vps26 antibody was a kind gift of
Matthew Seaman (University of Cambridge, UK).
MOTOR NEURON CULTURES
For the preparation of embryonic stem (ES) cell-derived
motor neurons, ES cells were maintained on fish skin gelatin
coated flasks in Glasgow Minimal Essential Medium (GMEM),
5% ES cell-qualified foetal bovine serum (FBS), 5% knock-
out serum replacement (KSR), 1% GLUTAMAX, 0.1mM
2-mercaptoethanol and 1000 units/ml of leukaemia inhibitory
factor (ESGRO, Millipore). To generate motor neurons, 1.5 ×
106 ES cells were grown in suspension on a 10 cm non-tissue
culture treated Petri dish containing differentiation (DFNK)
medium: 45% Neurobasal, 45% DMEM/Ham’s-F12, 10% KSR,
1% GLUTAMAX and 0.1mM 2-mercaptoethanol.
The following day, EBs were gently centrifuged and re-
suspended in 10ml of fresh DFNK medium and plated on a new
Petri dish. 24 h later, the greatly enlarged EBs were allowed to
sediment by gravity and re-suspended in fresh DFNK medium
supplemented with 1μM all-trans retinoic acid (RA) and 333 nM
Smoothened Agonist (SAG; Enzo Life Sciences). EBs were main-
tained under these conditions for a further 4 days with the
medium changed every other day. EBs were then dissociated with
0.025% porcine pancreatic trypsin in 1ml PBS for 7min at 37◦C
and processed as described previously for the dissociation of
mouse primary E13.5 spinal cord motor neurons (Hafezparast
et al., 2003).
Cells were plated onto poly-D-ornithine and laminin coated
dishes in motor neuron growth medium: neurobasal medium
supplemented with 2% B27, 2% heat-inactivated horse serum,
1% GLUTAMAX, 25μM 2-mercaptoethanol, 10 ng/ml rat ciliary
neurotrophic factor (CNTF; R&D Systems), 100 pg/ml rat glial
cell line-derived neurotrophic factor (GDNF; R&D Systems) and
1μM RA.
GENERATION OF HOMOZYGOUS RRP227 ES CELLS
Mouse ES cells with a gene-trap insertion in the first intron of
Bicd1 (RRP227; http://www.informatics.jax.org/javawi2/servlet/
WIFetch?page=alleleDetailandkey=544886) were obtained from
the Mutant Mouse Regional Resource Center. Homozygous
Bicd1gt/gt cells were generated as previously described in Lefebvre
et al. (2001) and Terenzio et al. (2014).
CELL TRANSFECTION
Full length mouse Bicd1 cDNA (MGC-27566, LGC Promochem)
was cloned into the EcoR1/BamH1 sites of the EGFP-N1 vec-
tor (Clontech) and microinjected into motor neurons as previ-
ously described (Deinhardt et al., 2006). BICD1-GFP expressing
cells were imaged after 24 h using an inverted LSM510 confocal
microscope (Zeiss). N2A cells were cultured and transfected as
previously described (Terenzio et al., 2014).
siRNA DELIVERY PROTOCOL OPTIMIZATION
An individual mix was prepared for 23 different lipid-based trans-
fection reagents (0.25μl of the reagent and 9.75μl OptiMEM per
well). Ten micro liters of this mixture were added to 10μl VAMP2
siRNA diluted in OptiMEM. The transfection mix was then dis-
pensed into each well of poly-D-ornithine/laminin coated 96-well
glass bottomed plates (IWAKI) and incubated at room tempera-
ture for 20min. For each well, 3.5 × 104 HBG3 ES cell-derived
motor neurons (Wichterle et al., 2002) suspended in 80μl of
motor neuron growth medium were plated on top of the trans-
fection mixture. After 72 h incubation, motor neurons we fixed
in 4% paraformaldehyde (PFA) and immunostained for VAMP2
and βIII tubulin.
The Thermo Scientific™ ArrayScan™ XTI High Content
Analysis Reader was used for automated image collection and
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image analysis was performed using the spot counting algorithm.
To assess transfection-related toxicity, each transfection reagent
was scored on the basis of the number of viable and morphologi-
cally intact motor neurons remaining after transfection. Based on
favorable cell viability scores and effective knockdown of VAMP2
protein levels, eight transfection reagents were then selected for
a second round of validation. Dreamfect Gold (OZ Biosciences)
was chosen to conduct the siRNA screen as it proved to be the
most effective in reliably inducing VAMP2 knock-down in both
primary and ES cell-derived motor neurons in a 96-well format
using the aforementioned reverse transfection protocol.
siRNA SCREENING
A master mix of Dreamfect Gold transfection reagent suffi-
cient for the entire siRNA library targeting 133 genes was pre-
pared (0.25μl Dreamfect Gold and 9.75μl OptiMEM per well)
and 10μl added to each well of another 96-well plate con-
taining 10μl siRNA (50 nM siRNA in OptiMEM) targeting a
single gene (Supplementary Table 1A, B). Twenty micro liters of
transfection mix were then dispensed into each well of poly-D-
ornithine/laminin coated 96-well glass bottomed plates (IWAKI)
and incubated at room temperature for 20min to 1 h. For each
well, 3.5 × 104 HBG3 ES cell derivedmotor neurons suspended in
80μl of motor neuron growth medium were plated on top of the
transfection mixture (50 nM final concentration for each siRNA).
The cells were then left to grow for 72 h before performing the
internalization assay.
To assess for probe internalization, the growth medium was
removed and replaced with Neurobasal medium containing
20 nM AlexaFluor555-conjugated HCT and 0.4μg/ml αp75NTR
(Deinhardt et al., 2007). Positive control wells previously incu-
bated with RISC-free siRNA (Qiagen) were additionally supple-
mented with 1mM EHNA. Motor neurons were then allowed
to internalize the probes at 37◦C for 2 h, cooled on ice for
5min, acid-washed (100mM citric acid pH 2.0, 142mM NaCl)
for 2min, washed and fixed with 4% w/v PFA for 20min. To
detect internalized αp75NTR, cells were immunostained with anti-
rabbit AlexaFluor647-conjugated secondary antibody. Finally,
each plate was sealed and 16 confocal Z-stacks were acquired
for each well using an inverted LSM510 confocal microscope
(Zeiss). Internalized probes were quantified using Cell Profiler as
described in the data quantification section.
TRANSMISSION ELECTRON MICROSCOPY
HCT was conjugated to colloidal gold by mixing 250μg of
purified HCT in 0.5ml of 2mM sodium tetraborate to 1ml
of colloidal gold particles (10 nm; British Biocell) as described
elsewhere Terenzio et al. (2014).
Motor neurons plated on coverslips were incubated with
20 nM nanogold-conjugated HCT for 2 h at 37◦C prior to wash-
ing. Cells were fixed in 2.5% glutaraldehyde, 4%PFA in Sorensen’s
phosphate buffer at room temperature for 20min, postfixed in
osmium tetroxide, stained with tannic acid and dehydrated pro-
gressively up to 100% ethanol. Finally, coverslips were embedded
in an Epon epoxy resin, sectioned (70–75 nm) and stained with
lead citrate. Images were acquired using a Tecnai Spirit Biotwin
(FEI) transmission electron microscope.
ASSESSMENT OF AXONAL RETROGRADE TRANSPORT
Axonal retrograde transport kinetics of HCT and αp75NTR in wild
type and in Bicd1gt/gt motor neurons was performed as previ-
ously described (Lalli and Schiavo, 2002; Deinhardt et al., 2006)
and quantified using Motion Analysis software (Kinetic Imaging)
(Bohnert and Schiavo, 2005; Deinhardt et al., 2006).
IMMUNOFLUORESCENCE
Motor neurons were seeded onto poly-D-ornithine and laminin-
coated coverslips and maintained under standard culture con-
ditions for 4–5 days. Cells were then fixed with 4% PFA for
15min at room temperature, washed and blocked with 2% bovine
serum albumin (BSA) in PBS containing 0.2% Triton X-100 for
20min at room temperature. Coverslips were then incubated for
1 h with primary antibodies followed by AlexaFluor-conjugated
secondary antibodies (1:500; Life Technologies). Finally, samples
were postfixed with PFA and mounted in Mowiol.
WESTERN BLOTTING
SDS-PAGE was performed using 4–12% NuPAGE Bis-Tris
gradient gels (Life Technologies) according to the manufac-
turer’s instructions and blotted onto polyvinylidene fluoride
(PVDF) membranes (Millipore). Membranes were blocked in 5%
skimmed milk dissolved in Tris-buffered saline (TBS) containing
0.05% Tween-20 (TBST) for 1 h at room temperature and then
incubated with primary antibodies diluted 1:1000 or 1:2000 in
TBST for 1 h at room temperature or overnight at 4◦C. Blots were
then washed and incubated with appropriate HRP-conjugated
secondary antibodies (GE Healthcare). Immunoreactivity was
detected using Luminata or Crescendo ECL substrates (Millipore)
and ECL-Hyperfilm (GE-Healthcare).
DATA QUANTIFICATION
Quantification of western blots and immunofluorescence staining
was performed using ImageJ for all experiments except the siRNA
screen and the validation re-screen. Typically, the fluorescence
staining of the area of interest was thresholded and the number
of thresholded voxels measured. Immunostaining for neuronal-
specific proteins, such as βIII tubulin, was used for normalization
purposes.
For the siRNA screen, image quantification of fluorescent HCT
and αp75NTR was performed using Cell Profiler (http://www.
cellprofiler.org). RGB images were split and the green GFP chan-
nel (motor neuron reporter) was used to create a cell mask,
which was then subtracted from the red AlexaFluor555-HCT and
blue AlexaFluor647-αp75NTR channels (Figure 2A). Individual
HCT and p75NTR-positive organelles were then identified in each
motor neuron and quantified.
RESULTS
VALIDATION OF ES CELL-DERIVED MOTOR NEURONS FOR
HIGH-THROUGHPUT IMAGE ANALYSIS
A key requisite to successfully perform an siRNA screen is the
ability to reliably and efficiently deliver RNA duplexes to the cyto-
plasm of target cells. However, motor neurons are notoriously
difficult to transfect using conditions that do not affect their
intracellular trafficking (Deinhardt and Schiavo, 2005). To over-
come this technical challenge, we established a lipid-based reverse
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FIGURE 1 | Optimization of the read-out for the siRNA screen. (A)
Representative images of GFP-positive HBG3 ES cell-derived motor neurons
(green) reverse transfected with Vamp2 siRNA using Dreamfect Gold in a
96-well plate format and immunostained for VAMP2 (red). Scale bar, 20μm.
(B)Western blot analysis of VAMP2 after siRNAmediated Vamp2 knock-down
in HBG3 ES cell-derived motor neurons transfected in a 96-well format. (C)
HBG3 ES cell-derived motor neurons expressing GFP (upper panels) were
incubated with AlexaFluor555-conjugated HCT (middle panels) and αp75NTR
(lower panels) in the presence of 1mM EHNA or DMSO vehicle control for 2 h
at 37◦C. Cells were then acid-washed, fixed and immunostained with
AlexaFluor488-conjugated anti-rabbit IgG. The intracellular accumulation of
both probes was substantially reduced by EHNA treatment, indicating that
cytoplasmic dynein plays a major role in this process. Scale bar, 20μm. (D,E)
Quantification of internalized HCT (D) and αp75NTR (E) in motor neurons
exposed to HCT and αp75NTR from three independent experiments with or
without EHNA (paired t-test, mean ± s.e.m., ∗∗∗p = 0.001).
transfection method in primary motor neurons, which could be
adapted to a 96-well plate format (see Material and Methods). To
optimize the conditions required for efficient gene knockdown
in preparation for the siRNA screen, we targeted VAMP2, since
loss of this abundant SNARE protein does not affect neuron sur-
vival (Schoch et al., 2001). After testing 23 different transfection
reagents, some of which are shown in Supplementary Figure 1,
Dreamfect Gold (OZ Biosciences) was chosen on the basis of
its ability to efficiently induce VAMP2 knockdown in primary
motor neurons 3 days after transfection. Importantly, DreamFect
Gold induced efficient depletion of VAMP2 without affecting cell
viability or morphology (data not shown).
Because of the limited amount of material and the intrinsic
cellular heterogeneity of embryo-derived primary motor neuron
cultures, we resorted to using transgenic HB9-GFP (HBG3) ES
cells to generate the large number of GFP-positive motor neurons
necessary for our screen and was a prerequisite for the medium
throughput imaging-based approach planned for this project.
HB9-GFP ES cells were readily expanded and differentiated
into motor neurons with the expression of GFP driven by the
Hb9 homeobox gene enhancer, which facilitates the unequiv-
ocal identification of motor neurons (Supplementary Figure 2)
(Wichterle et al., 2002). We then confirmed that the transfection
protocol previously optimized for primary cells in a 96-well for-
mat was also effective in efficiently knocking down VAMP2 in
HB9-GFP ES cell-derived motor neurons in the same format
(Figures 1A,B).
BIOLOGICAL READ-OUT OF THE siRNA SCREEN
The aim of our siRNA screen was to identify new components
of the machinery responsible for the uptake and intracellular
trafficking of HCT and p75NTR, with regulators of axonal ret-
rograde transport being of particular interest for us. However,
screening for changes in axonal transport in motor neurons using
an automated imaging approach is technically challenging since
it would require adapting our established live cell axonal retro-
grade transport assay (Lalli et al., 2003; Bohnert and Schiavo,
2005; Deinhardt et al., 2006; Restani et al., 2012) to a 96-well plate
format.
A simplified protocol was therefore used to monitor the
somatic accumulation of HCT and p75NTR in the cell body over
time, as a proxy for the retrograde transport of these probes from
the axonal network. Motor neurons were thus incubated with
fluorescent HCT and an antibody directed against the extracel-
lular domain of p75NTR (αp75NTR) for 2 h, before removing the
remaining surface-bound probes by acid washing and quantifying
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probe accumulation in the cell bodies of GFP-positive motor neu-
rons. Whilst the endocytosis of HCT into the somato-dendritic
compartment is very rapid, the onset of axonal transport of this
probe takes considerably longer (Bohnert and Schiavo, 2005).
We determined that 2 h was the ideal end point for our assay
because this allowed sufficient time for HCT internalized at dis-
tal entry sites to be transported and accumulate in the soma
(Supplementary Figure 3A).
The co-incubation of selected samples with EHNA, a
known inhibitor of the dynein-mediated retrograde trans-
port of HCT (Lalli et al., 2003), served as positive controls
for the decreased intracellular accumulation of both probes
(Figures 1C–E), which enter largely overlapping trafficking path-
ways (Lalli and Schiavo, 2002; Deinhardt et al., 2006). However,
in contrast to the overt effect of EHNA on HCT accumu-
lation, which was visible throughout the time frame of the
assay (Supplementary Figure 3A), the effects of dynein inhibi-
tion on p75NTR accumulation only became apparent after 90min
(Supplementary Figure 3B).
Notably, the internalization kinetics of αp75NTR when incu-
bated alone overlapped with the αp75NTR accumulation profile
when cells were co-incubated with this antibody together with
HCT and EHNA (Supplementary Figure 3B). This result was not
unexpected since it agrees with previous findings showing that
in the absence of HCT or neurotrophins, p75NTR enters a local
fast recycling pathway, and as such does not undergo long-range
dynein mediated transport (Deinhardt et al., 2007). Therefore,
treatment of motor neurons with EHNA in the absence of HCT
was not expected to alter αp75NTR accumulation (see Discussion).
siRNA SCREENING FOR MODULATORS OF AXONAL RETROGRADE
TRANSPORT AND ENDOCYTIC SORTING
Having established a robust experimental platform for the siRNA
screen, HB9-GFP motor neurons were then transfected with a
custom-selected siRNA library targeting molecular motors, their
adaptors and associated proteins, which have been reported to
regulate motor activity (Supplementary Table 1A). To monitor
knockdown efficiency under the experimental conditions used
for the screen, we determined the down-regulation of VAMP2 in
the three independent replicates assayed from the 96-well plates
used for the actual screen. As shown in Supplementary Figure 4,
VAMP2 knockdown in Vamp2 siRNA treated wells was consis-
tently 80% or greater.
The accumulation of HCT and αp75NTR was quantified for
all siRNAs by scoring the average number of HCT- and p75NTR-
positive puncta per motor neuron using confocal microscopy
followed by multi-parametric image analysis (Figure 2A) and
represented as Z-scores (Figure 2B). Candidate hits were selected
based on their standard deviations from the mean values for
the whole siRNA library (see Materials and Methods and
Supplementary Tables 1C,D) and are highlighted on the Z-score
profile (Figure 2B).
From this primary analysis, 23 candidate genes for HCT and
28 for αp75NTR were taken forward for validation using siRNA
pools from a different supplier. The same assay was then per-
formed for the re-screen except that hits were instead selected
based on the standard deviation from the mean of the siRNA
FIGURE 2 | Summary of the siRNA screen. (A) Image analysis pipeline
used for the siRNA screen. Representative images of GFP-positive motor
neurons used to create image masks (top right panels), from which images
of internalized HCT and p75NTR were quantified. Scale bar, 10μm. (B)
Sigma plot of the Z-scores obtained for internalized HCT (gray circles) and
p75NTR (black circles) for the entire siRNA library (see Table S1). Candidates
that produced statistically significant increased (Z-score: >1) or decreased
(Z-score: <1) accumulation phenotypes are shown in green (HCT) or violet
(p75NTR). EHNA-treated positive controls are shown in red.
controls (Supplementary Tables 1E–G). RNAi of seven genes
was confirmed to decrease probe accumulation, whereas only
one gene for each probe was validated to induce the oppo-
site effect (Supplementary Tables 1F,G). Rab7 knockdown led
to an increased intracellular accumulation of αp75NTR (see
Discussion), whilst the only silenced gene that was confirmed to
boost the intracellular build-up of HCT was Bicd1 (Figure 2B and
Supplementary Tables 1F,G).
We decided to focus our efforts on addressing the role
played by BICD1 in HCT trafficking in our model system since
BICD1 and the related proteins BICD2 and BICDR1/2 have been
described as microtubule-associated proteins and motor adap-
tors (Hoogenraad et al., 2001; Matanis et al., 2002; Schlager et al.,
2010; Terenzio and Schiavo, 2010). Furthermore, BICD1 was pro-
posed to play a role in axonal retrograde transport in neurons
(Wanschers et al., 2007).
THE AXONAL RETROGRADE TRANSPORT OF HCT IS NOT AFFECTED IN
Bicdl gt/gt MOTOR NEURONS
Although RNA interference has emerged as a key strategy to
analyse the function of mammalian genes and much work has
centered on siRNA design to improve target specificity, indi-
vidual siRNAs have nevertheless been shown to down-regulate
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unrelated genes by binding to the 3′ untranslated regions of
mRNAs resulting in off-target effects (Echeverri et al., 2006).
To discount this possibility and confirm the specificity of the
HCT accumulation phenotype induced by Bicd1 knockdown,
we independently assessed the effects of BICD1 depletion in
motor neurons derived from an ES cell line engineered to carry
a Bicd1 gene trapped allele, Bicd1gt/+ (Terenzio et al., 2014).
Motor neurons derived from ES cells homozygous for this muta-
tion (Bicd1gt/gt) expressed 70% lower BICD1 protein compared
to wild type cells. Importantly, Bicd1gt/gt motor neurons were
indistinguishable from Bicd1gt/+ and wild-type ES cell-derived
motor neurons in terms of synaptic density or neurite differen-
tiation (Terenzio et al., 2014). As such, Bicd1gt/gt motor neurons
are an ideal model to study the effects of BICD1 depletion onHCT
trafficking.
Confirming the previous findings linking BICD1 to axonal
transport (Wanschers et al., 2007), BICD1-GFP transfected into
wild-type motor neurons underwent robust retrograde transport
along the axonal network (Figure 3A). However, in spite of the
reported interaction of BICD1 with cytoplasmic dynein, BICD1
does not appear to play a direct role in this pathway, since axonal
retrograde transport of HCT was not perturbed in Bicd1gt/gt
motor neurons (Figure 3B).
BICD1 DEPLETION ENHANCES THE SOMATIC ACCUMULATION OF HCT
To confirm that the depletion of BICD1 in Bicd1gt/gt motor
neurons replicated the HCT accumulation phenotype identified
during the siRNA screen, identical probe accumulation assays
were performed using Bicd1gt/+ and Bicd1gt/gt motor neurons.
Thus, HCT and αp75NTR were incubated together to trigger the
internalization of p75NTR via a clathrin-dependent route linked to
axonal retrograde transport (Deinhardt et al., 2007). Probe inter-
nalization was quantified at 15, 30, and 60min of incubation at
37◦C, which demonstrated that the intracellular accumulation of
both HCT and αp75NTR was significantly increased in Bicd1gt/gt
motor neurons after 60min (Supplementary Figure 5). This phe-
notype was also detected in Bicd1gt/+ cells, although it was
statistically significant only for p75NTR under these experimental
conditions (Supplementary Figure 5B).
These data supported the results of our siRNA screen and
further confirmed that depletion of BICD1 causes an increased
somatic accumulation of HCT.However, a similar phenotype for
the p75NTR antibody was also observed in the Bicd1gt/+ model
system, prompting us to further investigate the effects of BICD1
depletion on the trafficking of the neurotrophin receptors p75NTR
and TrkB, which are described elsewhere (Terenzio et al., 2014).
Altogether, our data indicate that BICD1 functions as a regulator
of the somatic sorting of signaling endosomes containing in HCT
and neurotrophin receptors. However, this manuscript focuses
primarily on investigating the regulatory role of BICD1 on HCT
trafficking.
BICD1 DEPLETION CAUSED THE INCREASED ASSOCIATION OF HCT
WITH ENDOSOMAL SORTING COMPARTMENTS
In order to investigate the precise trafficking step affected by
BICD1 depletion, we used transmission electron microscopy to
trace the intracellular fate of internalized nanogold-conjugated
HCT in wild type and Bicd1gt/gt motor neurons. As previously
reported, colloidal gold-conjugated HCT undergoes rapid inter-
nalization followed by axonal retrograde transport and accu-
mulates in organelles resembling tubular endosomes and multi-
vesicular bodies (MBV) (Parton et al., 1987; Lalli et al., 2003).
Whilst this distribution pattern of HCT was confirmed in wild-
type motor neurons (Figure 4A), BICD1 depletion induced a
preferential accumulation in HCT and enlarged organelles with
amorphous content, which were localized in the cell body of
Bicd1gt/gt motor neurons (Figures 4B–D). These organelles con-
tained clustered gold-conjugated HCT, which was localized close
to the limitingmembrane and occasionally within buds or tubules
emerging from these structures (Figure 4B).
FIGURE 3 | Axonal retrograde transport of HCT is not perturbed in
Bicd1gt/gt motor neurons. (A) Representative images taken from a
time-lapse movie showing retrograde movement of BICD1-GFP
(arrowheads) along the axon of a wild type motor neuron. Scale bar,
5μm. (B) Speed distribution profiles of axonal AlexaFluor-conjugated
HCT-positive carriers undergoing axonal retrograde transport in wild type
(black squares) and Bicd1gt/gt (red squares) motor neurons (mean ±
s.e.m.).
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FIGURE 4 | Morphology of HCT-containing organelles in wild type and
Bicd1gt/gt motor neurons. (A) Transmission electron microscopy image
of a typical endosome containing gold-conjugated HCT (white arrowhead)
in wild type motor neurons. HCT was internalized for 2 h at 37◦C. Scale
bar, 200 nm. (B–D) Transmission electron microscopy images of
representative organelles containing gold-conjugated HCT (white
arrowheads) in Bicd1gt/gt motor neurons following internalization for 2 h
at 37◦C. HCT was often detected in budding structures (B, yellow
arrowhead), or enlarged endosomal organelles containing membranes (C)
or with an amorphous content (D). In several instances, gold-conjugated
HCT was found clustered at the limiting membrane of these structures.
Scale bar, 200 nm.
We believe that the organelles containing large clusters of
gold-conjugatedHCT represent enlarged endosomal sorting com-
partments. This view is supported by the observation that HCT
co-localized with components of the retromer complex, such as
Vps26 (Figures 5A,B) and sorting nexin 1 (SNX1) (Terenzio et al.,
2014). Furthermore, BICD1 was found to partially co-distribute
with selected endosomal markers, such as VTI1B (Figure 5C), a
SNARE protein involved in late endosome to lysosome traffick-
ing (Offenhauser et al., 2011). This result suggested that BICD1
might be important for this sorting route, which normally con-
trols the down-regulation of ligand-activated receptor complexes.
However, we never observed any co-localization between HCT
and BICD1 (Figure 5D) or VTI1B (data not shown), suggest-
ing either that the association of BICD1 with these markers was
below the detection limits of our assays, or that BICD1 affected
HCT behavior indirectly by altering endosomal sorting steps
downstream of SNX1.
BICD1 DEPLETION INCREASES HCT BINDING TO THE NEURONAL
PLASMAMEMBRANE
The retromer complex is an essential component of the endoso-
mal protein sorting machinery, which regulates the retrieval of
cargoes in transit through the endosomal pathway to the Golgi or
their re-targeting back to the plasma membrane. Misregulation
of retromer-mediated sorting impairs these processes and causes
severe neurological diseases, such as hereditary spastic paraplegia
(Seaman, 2012). Whereas targeting to the Golgi was unaffected
by BICD1 depletion (Terenzio et al., 2014 and data not shown),
the binding of HCT to the plasma membrane was significantly
enhanced in Bicd1gt/gt motor neurons compared to wild-type cells
(Figure 6). Similarly, TrkB and p75 also showed increased accu-
mulation on the plasma membrane of mutant neurons (Terenzio
et al., 2014).
DISCUSSION
In this work, we have developed a novel siRNA screening
approach designed to identify new players involved in the inter-
nalization and trafficking of tetanus toxin and neurotrophin
receptor complexes in motor neurons. We designed an imaging-
based assay using a 96-well plate format, which allowed us to
screen a custom-selected siRNA library for genes affecting the
trafficking of neurotropic probes. Important considerations for
protocol design included the selection of appropriate fluorescent
probes and a relevant cell model to monitor their intracellular
trafficking.
To this end, we chose HCT because of our long-standing inter-
est in studying the molecular mechanisms responsible for the
binding, internalization and intracellular trafficking of tetanus
neurotoxin, which continues to pose a serious threat to human
health in the developing world. The second probe used in
this study was an antibody against the extracellular domain of
p75NTR, which has previously been shown to act as a reliable
tool to monitor the internalization and long-range transport of
p75NTR in a ligand-dependent manner (Deinhardt et al., 2007).
Upon addition of neurotrophins, this antibody enters signal-
ing endosomes containing HCT and Trk receptors, which are
retrogradely transported along the axon (Deinhardt et al., 2006).
Motor neurons are the most physiologically relevant model
system with which to perform such a screen. We used HBG3 ES
cells for differentiating large numbers of GFP-expressing motor
neurons, which could be easily imaged for the quantification of
fluorescent probe accumulation.
One aspect of the screen that underwent extensive optimiza-
tion was the timing of internalization of the two probes. We
performed a kinetic analysis of HCT and p75NTR internalization
(Supplementary Figure 3) and established that the two probes
behaved differently in their response to the cytoplasmic dynein
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FIGURE 5 | HCT partially co-distributes with retromer components and
late endosomal SNAREs. (A) Wild type and Bicd1gt/gt motor neurons
were incubated with AlexaFluor555-conjugated HCT (red) for 1 h at 37◦C,
then acid-washed, fixed and immunostained for Vps26 (green). Insets from
the merged images are magnified to show co-localization (yellow) between
HCT and Vps26. Scale bar, 5μm. (B) Quantification of HCT/Vps26
co-localization from the experiment shown in (A) (16 cells per condition,
Mann-Whitney test, mean ± s.e.m., n.s. non-significant). (C) N2A cells
over-expressing BICD1-GFP (green) were fixed and immunostained for
VTI1B (red). The white box in the merged channel is magnified to highlight
the extent of co-localization of BICD1-GFP and this late endosomal SNARE
protein. Scale bar, 20μm. (D) Wild type motor neurons were incubated
with AlexaFluor488-conjugated HCT (green) for 1 h at 37◦C, acid-washed,
fixed and then immunostained for BICD1 (red). Co-localization between
HCT and BICD1 was not detected under these conditions. Scale bar,
20μm.
inhibitor EHNA, which was used in our screen as a positive
control for inhibition of axonal transport. EHNA inhibited the
accumulation of HCT, even from the earliest time points, whereas
this inhibitor affected p75NTR accumulation only after 90min. A
possible explanation for this phenomenon is that in the absence
of neurotrophins, p75NTR enters a local recycling pathway and
does not undergo long-range axonal retrograde transport. Hence,
treatment with EHNA would not be expected to change p75NTR
accumulation in the absence of any cognate ligands. However,
HCT is known to promote p75NTR axonal transport (Deinhardt
et al., 2007), thereby increasing the delivery of this receptor to the
soma. This may be the most likely explanation for the increased
p75NTR accumulation in the presence of HCT and that EHNA-
induced effects for p75 were only noted from 90min onwards.
Our screen identified several genes that affected the internal-
ization and/or accumulation of HCT and αp75NTR. For example,
the knockdown of Rab7 increased the intracellular accumulation
of p75NTR (Figure 2B and Supplementary Table 1G), possi-
bly due to the defective progression of this receptor along the
endosomal pathway, a process known to be regulated by Rab7
(Stenmark, 2009; Mizuno-Yamasaki et al., 2012). This result is
in agreement with the accumulation of NGF-activated TrkA in
enlarged endosomes in PC12 cells overexpressing a dominant-
negative Rab7 mutant (Saxena et al., 2005). Although our screen
was performed in the absence of exogenous neurotrophins,
HCT has been found to activate neurotrophin signaling in a
Trk-dependent manner (Calvo et al., 2012), and therefore may
direct p75NTR toward a long-range axonal trafficking pathway,
which is normally only followed by ligand-activated receptors
(Deinhardt et al., 2007).
Since the uptake and axonal transport of HCT and p75NTR
share a common route (Bercsenyi et al., 2013; Schmieg et al.,
2013), it was perhaps surprising that our screen failed to identify
any gene equally affecting the intracellular dynamics of both
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probes. For instance, the cytoplasmic dynein/dynactin complex
is known to play a key role in the axonal retrograde transport
of both HCT and p75NTR (Bercsenyi et al., 2013). Of the many
cytoplasmic dynein and dynactin genes that we screened, only the
knockdown of dynein light chain Tctex-3 (Dynlt3) and p150Glued
(Dcnt1) reduced the accumulation of HCT without affecting
intracellular increase of αp75NTR (Figure 2B and Supplementary
Tables 1F,G). One possible explanation for this unexpected result
is that the internalization and transport of HCT and p75NTR are
differentially sensitive to the degree of silencing of genes that regu-
late their trafficking, such as dynein/dynactin subunits or specific
Rab GTPases. Decreased accumulation phenotypes were more
common for anterograde kinesin heavy chains, such as KIF11,
KIF15, and KIF21B (Figure 2B and Supplementary Tables 1F,G).
Experiments aimed at addressing the function of these kinesins
in neurotrophin receptor trafficking will be the focus of future
studies.
Since tetanus toxin traffics to the central nervous system by
dynein-mediated retrograde transport and BICD1 is a known
cytoplasmic dynein adaptor, we concentrated our efforts on
investigating how BICD1 depletion affected the accumulation of
HCT in motor neurons. Our results suggest that BICD1 regu-
lates HCT trafficking, which may provide insights into how this
dynein adaptor might influence tetanus toxin behavior in vivo.
Furthermore, BICD1 is known to play diverse roles in the devel-
opment and maintenance of the nervous system (Matanis et al.,
2002; Schlager et al., 2010) yet its mechanism of action in this
context has not been established. Because BICD1 was proposed
to play a role in axonal retrograde transport (Wanschers et al.,
2007) and is transported along axons (Figure 3A), we postulated
that BICD1 depletion might interfere with long-range axonal
trafficking of signaling endosomes containing HCT and p75NTR.
However, the axonal retrograde transport of HCT was not per-
turbed in Bicd1gt/gt motor neurons (Figure 3B). Similarly, axonal
trafficking of p75NTR was also unaffected in Bicd1gt/gt motor
neurons upon BDNF stimulation (Terenzio et al., 2014), suggest-
ing that either BICD1 is not essential for the long-range axonal
trafficking of HCT and p75NTR, or that the residual BICD1 pro-
tein level in Bicd1gt/gt motor neurons is sufficient to support the
recruitment of cytoplasmic dynein to HCT-containing signaling
endosomes and/or the regulation of dynein activity associated
with these endosomes.
Recently, the mechanisms responsible for cargo sorting within
signaling endosomes and the fate of ligand-receptor complexes
upon arrival in the cell body have gained mounting interest.
Based on our analysis of HCT trafficking, we hypothesized that
BICD1 was likely to have a role in the somatic sorting of
this probe. In support of this view, electron microscopy anal-
yses performed in motor neurons depleted of BICD1 demon-
strated that gold-conjugated HCT exhibited a higher association
with enlarged membrane compartments, where it clustered close
to the limiting membrane, sometimes within bud-like struc-
tures connected to these organelles (Figure 4). This finding sug-
gested that BICD1 is involved in the regulation of the endo-
somal trafficking of HCT and neurotrophin receptor complexes
and that its depletion alters cargo flow within the endosomal
pathway.
FIGURE 6 | Bicd1gt/gt motor neurons have increased cell surface
binding of HCT. (A) Wild type and Bicd1gt/gt motor neurons were
incubated on ice for 15min with AlexaFluor555-conjugated HCT (grayscale)
and fixed. Scale bar = 20μm. A heat map representation of HCT staining
has been added to better visualize the differences in binding between the
two genotypes (right panels). (B) Quantification of the cell surface pool of
HCT from three independent experiments (t-test, mean ± s.e.m.,
∗p < 0.05).
The retromer complex is a crucial component of the endo-
somal sorting machinery, and plays major roles in endosome to
Golgi retrieval and endosome to plasmamembrane recycling pro-
cesses, through interactions with members of the sorting nexin
(SNX) family (Seaman, 2012). Recently, more than 100 plasma
membrane proteins were found to bind to SNX27, including
the neurotrophin receptor scaffolding protein Kidins220/ARMS
(Steinberg et al., 2013). Importantly, SNX27 is required to main-
tain plasma membrane levels of these proteins by promoting
their recycling and preventing their degradation (Steinberg et al.,
2013).We found that HCT colocalizes with retromer components,
such as Vps26 (Figure 5A), and SNX1 (Terenzio et al., 2014).
Crucially, the co-distribution of HCT with SNX1-positive com-
partments was higher in Bicd1gt/gt motor neurons compared to
wild type cells, suggesting that SNX1-dependent sorting of HCT
and associated cargoes was affected by BICD1 depletion (Terenzio
et al., 2014).
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FIGURE 7 | Proposed role of BICD1 in HCT trafficking. In wild type motor
neurons, HCT binds to plasma membrane receptors, which include
polysialogangliosides and is internalized at synaptic sites located in the
periphery (1); note that for clarity, internalization of HCT along the axon and in
the soma is not shown. HCT and neurotrophin-receptor complexes are sorted
to signaling endosomes (2), which are retrogradely transported by
cytoplasmic dynein (3), toward the cell soma. Here, they associate with
somatic sorting endosomes (4) decorated by sorting nexin 1 (SNX1) and
other retromer components. Neurotrophin receptors are then trafficked
toward MVB/lysosomes (5) for degradation, whilst HCT is recycled to the
plasma membrane (6). Impairment of the lysosomal targeting of TrkB and
other proteins, including HCT receptors, in neurons lacking BICD1 is
envisaged to mainly redirect them to the recycling route back to the plasma
membrane. The main consequence of these miss-sorting steps is an
increase in HCT binding sites and neurotrophin receptors (Terenzio et al.,
2014) on the cell surface at steady state.
Supporting our proposed role for BICD1 in endosomal sort-
ing, depletion of BICD1 increased plasma membrane levels of
HCT (Figure 6) as well as the neurotrophin-dependent recycling
of p75NTR and TrkB to the plasma membrane (Terenzio et al.,
2014). At the present time, we do not have a molecular expla-
nation for the increased cell surface binding of HCT by Bicd1gt/gt
motor neurons, but it is likely to relate to increased toxin receptor
levels at the plasma membrane. Even though the protein recep-
tor of HCT is not known (Bercsenyi et al., 2013), this probe
co-localizes with TrkB, undergoes axonal retrograde transport
with this receptor (Deinhardt et al., 2006) and activates signaling
cascades downstream of Trks in cortical and hippocampal neu-
rons (Gil et al., 2000, 2003; Calvo et al., 2012).
Based on these results, we would like to propose a model
by which BICD1 controls the sorting of cargoes within axonal
signaling endosomes and subsequently directs them to appropri-
ate degradation or recycling routes (Figure 7). This role, which
is required for optimal neurotrophin signaling (Terenzio et al.,
2014), is also likely to control the trafficking of pathogens and
virulence factors, such as tetanus neurotoxin and its binding frag-
ment HCT, which exploit axonal signaling endosomes for their
entry and dissemination in the nervous system (Salinas et al.,
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2010; Schmieg et al., 2013). In this light, modulating BICD1 activ-
ity could have potential therapeutic effects on the controlling
the infectivity and/or spreading of viruses and toxins, and may
be exploited to improve the efficiency of gene therapy vectors
targeting the nervous system.
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Supplementary Figure 1 | Optimization of the transfection protocol.
(A) VAMP2 knockdown in primary motor neurons using different
transfection reagents in a 96 well plate format. The spot count for
VAMP2-positive vesicles for the reagents that proved non-toxic (12 out of
the original 23) are shown. 2 different VAMP2 siRNA concentrations, 50
and 100 nM, were used for each reagent. (B) The most effective eight
reagents from (A) were re-screened using the same protocol, but using
three different concentrations of each reagent. The quantity of each
reagent used is indicated. Samples treated with the indicated reagent and
the siRNA control pool or the VAMP2 siRNA pool are indicated by S or V,
respectively (n = 3). (C) The most effective four reagents from panel B
were tested for their ability to induce knockdown of VAMP2. Western
blotting of cell lysates demonstrated that all four reagents proved to be
effective in downregulating VAMP2.
Supplementary Figure 2 | Derivation of motor neurons from mouse
embryonic stem cells. (A) Flow diagram describing the protocol used for
the differentiation of motor neurons from mouse HB9-GFP ES cells. After
growth in suspension in differentiating medium for 3 days, the ES cells
form embryoid bodies (EBs) comprising neuronal progenitor cells (NPC).
These NPCs are then induced to commit to a motor neuron fate (indicated
by GFP expression) by the addition of retinoic acid (RA) and Smoothened
Agonist (SAG), a small molecule activator of sonic hedgehog signaling. At
the end of the fourth day in the presence of these differentiating agents,
the EBs are dissociated and motor neurons plated. Scale bar, 10μm. (B)
HB9-GFP ES cell derived motor neurons (GFP, green) 4 days after plating
and immunostained for GFP (red) and the pan neuronal marker, βIII tubulin
(blue). Note the characteristically long motor neuron axon (arrowhead),
arising for the soma (asterisk). Scale bar, 50μm.
Supplementary Figure 3 | Kinetics of HCT and p75NTR antibody
internalization. (A) HCT accumulation kinetics in motor neurons derived
from HB9-GFP ES cells in the presence of αp75NTR and the presence (red)
or absence (black) of EHNA (n = 3). Note that HCT accumulation was
significantly decreased in the presence of EHNA (p < 0.0001, Two-Ways
ANOVA). (B) Accumulation kinetics of the p75NTR antibody (αp75NTR)
when co-incubated with HCT in motor neurons derived from HB9-GFP ES
cells in the absence (black) or presence (red) of EHNA (n = 3). Note that
the receptor accumulation profiles generated from EHNA-treated samples
diverge from the control plot only after 75min (p < 0.0001, Two-Ways
ANOVA). Importantly, in the absence of HCT, the internalization kinetics of
the p75NTR antibody (blue) overlapped with the internalization profile
observed for this probe when it was co-incubated with HCT
and EHNA.
Supplementary Figure 4 | Assessment of knockdown efficiency of the
siRNA screen. Five wells from each plate of the siRNA screen were
treated with non-targeting control siRNA and five wells with VAMP2
siRNA. Protein lysates from each set of samples for each plate were
pooled and analyzed by western blot to assess VAMP2 knockdown
efficiency with βIII tubulin serving as a loading control.
Supplementary Figure 5 | Internalization kinetics of HCT and p75NTR
antibody in wild type, Bicd1gt/+ and Bicd1gt/gt motor neurons. (A) HCT
internalization kinetics were assessed in wild type, Bicd1gt/+ and
Bicd1gt/gt motor neurons. At the 60min time point, a statistically
significant increase in HCT accumulation was confirmed for Bicd1gt/gt
motor neurons compared to wild type cells. (ANOVA test, followed by
Bonferroni post-test, n = 3. Results are shown ± s.e.m.). (B) αp75NTR
antibody internalization kinetics were assessed in wild type, Bicd1gt/+ and
Bicd1gt/gt motor neurons. A statistically significant difference between the
three genotypes was observed at the 60min time point. Statistical
significance was calculated using a One-Way ANOVA test, followed by
Bonferroni post-test, n = 3. Results are shown ± s.e.m.
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